GSK Rg
GSK
GBP
STOCK MARKET:
LSS
Closed
 
...
Large gap with delayed quotes
Official
07/01/2025 - 17:35:25
Bid
07/01/2025 - 18:30:00
Bid
Volume
Ask
07/01/2025 - 18:30:00
Ask
Volume
14.1250
+0.225 ( +1.62% )
13.8000
300
14.9000
350
More information
Analysis by TheScreener
27.06.2025
Evaluation Slightly positive  
Interest Weak  
Sensibility Low  
Analysis date: 27.06.2025
Global Evaluation
  Slightly positive
The stock is classified in the slightly positive zone since 27.06.2025.
Interest
  Weak
Two stars since 27.06.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 10.06.2025 at a price of 1508.50.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
  Negative
 
The forty day technical trend is negative since 20.06.2025.
4wk Rel Perf
  -1.36%
 
The four-week dividend-adjusted underperformance versus STOXX600 is 1.36%.
Sensibility
  Low
The stock has been on the low-sensitivity level since 04.03.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.13%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.05%.
Mkt Cap in $bn
  78.05
With a market capitalization >$8bn, GLAXOSMITHKLINE is considered a large-cap stock.
G/PE Ratio
  1.68
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
  6.83
The estimated PE is for the year 2028.
LT Growth
  6.81%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
  15
Over the last seven weeks, an average of 15 analysts provided earnings per share estimates.
Dividend Yield
  4.66%
The twelve month estimated dividend yield represents 31.83% of earnings forecasts.
Beta
  60
For 1% of index variation, the stock varies on average by 0.60%.
Correlation
  0.42
41.56% of stock movements are explained by index variations.
Value at Risk
  84.47
The value at risk is estimated at GBp 84.47. The risk is therefore 6.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002